These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 19089570)
21. Involvement of the eyebrow fat pad in Graves' orbitopathy. Goldberger S; Sarraf D; Bernstein JM; Hurwitz JJ Ophthalmic Plast Reconstr Surg; 1994 Jun; 10(2):80-6. PubMed ID: 8086367 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy]. Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504 [TBL] [Abstract][Full Text] [Related]
23. Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves' orbitopathy. Saber E; McDonnell J; Zimmermann KM; Yugar JE; Feldon SE Graefes Arch Clin Exp Ophthalmol; 1996 May; 234(5):331-6. PubMed ID: 8740255 [TBL] [Abstract][Full Text] [Related]
24. Color Doppler imaging of orbital vasculature before and after orbital decompression in thyroid eye disease. Jamshidian-Tehrani M; Nekoozadeh S; Alami E; Ghadimi H; Nabavi A; Ameli K; Sharif Kashani S; Kashkouli MB; Sadeghi-Tari A Orbit; 2019 Jun; 38(3):173-179. PubMed ID: 30142011 [No Abstract] [Full Text] [Related]
26. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy. Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519 [TBL] [Abstract][Full Text] [Related]
27. Color Doppler imaging in thyroid eye disease and its correlation to disease activity. Jamshidian-Tehrani M; Nabavi A; Kasaee A; Hasanpoor N; Elhami E; Sharif-Kashani S; Masoumi A; Nowroozzadeh MH; Sadeghi-Tari A Orbit; 2019 Dec; 38(6):440-445. PubMed ID: 30628510 [No Abstract] [Full Text] [Related]
28. Changes in peripapillary blood vessel density in Graves' orbitopathy after orbital decompression surgery as measured by optical coherence tomography angiography. Lewis KT; Bullock JR; Drumright RT; Olsen MJ; Penman AD Orbit; 2019 Apr; 38(2):87-94. PubMed ID: 29517388 [TBL] [Abstract][Full Text] [Related]
29. Quantification of blood flow in the superior ophthalmic vein using phase contrast magnetic resonance imaging. Promelle V; Bouzerar R; Milazzo S; Balédent O Exp Eye Res; 2018 Nov; 176():40-45. PubMed ID: 29959927 [TBL] [Abstract][Full Text] [Related]
30. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Lyons CJ; Rootman J Ophthalmology; 1994 Feb; 101(2):223-30. PubMed ID: 8115142 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy. Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240 [TBL] [Abstract][Full Text] [Related]
32. Current insights into animal models of Graves' disease and orbitopathy. Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015 [TBL] [Abstract][Full Text] [Related]
33. The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Kendler DL; Lippa J; Rootman J Arch Ophthalmol; 1993 Feb; 111(2):197-201. PubMed ID: 8431156 [TBL] [Abstract][Full Text] [Related]
34. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study. Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054 [TBL] [Abstract][Full Text] [Related]